News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

Deanna Kepka, PhD, MPH

Advertisement

Articles by Deanna Kepka, PhD, MPH

Risk for Cancer-Causing Infections Highest in Low- and Middle-Income Countries

ByDeanna Kepka, PhD, MPH
August 10th 2017

Despite the progress that has been made, more research is needed on cancer prevention, hepatitis B, and human papillomavirus vaccines.

Advertisement

Latest Updated Articles

  • Risk for Cancer-Causing Infections Highest in Low- and Middle-Income Countries
    Risk for Cancer-Causing Infections Highest in Low- and Middle-Income Countries

    Published: August 10th 2017 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

Ethiopia Investigates Marburg Virus Disease Outbreak

2

World AIDS Day 2025: Global Setbacks and New Strategies to Sustain Progress Toward 2030 HIV Targets

3

Scynexis Collaborates With Hackensack Meridian CDI, Johns Hopkins to Develop Therapeutics for Drug-Resistant Fungal Infections

4

HIV Drug Resistance Declines in the Modern ART Era

5

Top Infectious Disease News Stories Week of November 22 - November 28

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us